Annual Total Expenses
$17.54 M
-$4.35 M-19.87%
December 31, 2023
Summary
- As of February 8, 2025, WINT annual total expenses is $17.54 million, with the most recent change of -$4.35 million (-19.87%) on December 31, 2023.
- During the last 3 years, WINT annual total expenses has fallen by -$12.78 million (-42.15%).
- WINT annual total expenses is now -61.95% below its all-time high of $46.09 million, reached on December 31, 2014.
Performance
WINT Total Expenses Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Total Expenses
$4.74 M
-$6.71 M-58.60%
September 30, 2024
Summary
- As of February 8, 2025, WINT quarterly total expenses is $4.74 million, with the most recent change of -$6.71 million (-58.60%) on September 30, 2024.
- Over the past year, WINT quarterly total expenses has increased by +$51.00 thousand (+1.09%).
- WINT quarterly total expenses is now -70.91% below its all-time high of $16.30 million, reached on March 31, 2006.
Performance
WINT Quarterly Total Expenses Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Total Expenses Formula
Total Expenses = Cost of Goods Sold + Operating Expenses + Non Operating Expenses
WINT Total Expenses Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -19.9% | +1.1% |
| 3 y3 years | -42.1% | +27.9% |
| 5 y5 years | -2.5% | +27.9% |
WINT Total Expenses Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -45.6% | at low | -58.6% | +37.1% |
| 5 y | 5-year | -45.6% | at low | -58.6% | +37.1% |
| alltime | all time | -62.0% | +601.6% | -70.9% | +1480.3% |
Windtree Therapeutics Total Expenses History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | $4.74 M(-58.6%) |
| Jun 2024 | - | $11.45 M(+160.0%) |
| Mar 2024 | - | $4.41 M(-11.2%) |
| Dec 2023 | $17.54 M(-19.9%) | $4.96 M(+5.7%) |
| Sep 2023 | - | $4.69 M(+12.1%) |
| Jun 2023 | - | $4.18 M(+12.8%) |
| Mar 2023 | - | $3.71 M(+7.2%) |
| Dec 2022 | $21.89 M(-32.1%) | $3.46 M(-17.6%) |
| Sep 2022 | - | $4.20 M(-28.9%) |
| Jun 2022 | - | $5.90 M(-29.2%) |
| Mar 2022 | - | $8.33 M(+12.0%) |
| Dec 2021 | $32.26 M(+6.4%) | $7.44 M(-8.7%) |
| Sep 2021 | - | $8.15 M(+7.3%) |
| Jun 2021 | - | $7.59 M(-16.4%) |
| Mar 2021 | - | $9.08 M(+30.4%) |
| Dec 2020 | $30.32 M(+20.8%) | $6.96 M(-20.0%) |
| Sep 2020 | - | $8.71 M(+9.5%) |
| Jun 2020 | - | $7.95 M(+18.6%) |
| Mar 2020 | - | $6.70 M(+47.2%) |
| Dec 2019 | $25.09 M(+39.5%) | $4.55 M(-36.6%) |
| Sep 2019 | - | $7.19 M(+8.0%) |
| Jun 2019 | - | $6.65 M(-0.7%) |
| Mar 2019 | - | $6.70 M(+29.9%) |
| Dec 2018 | $17.98 M(-25.2%) | $5.16 M(+39.4%) |
| Sep 2018 | - | $3.70 M(-9.5%) |
| Jun 2018 | - | $4.09 M(-19.0%) |
| Mar 2018 | - | $5.04 M(+40.1%) |
| Dec 2017 | $24.03 M(-40.0%) | $3.60 M(-25.2%) |
| Sep 2017 | - | $4.81 M(-34.0%) |
| Jun 2017 | - | $7.29 M(-12.6%) |
| Mar 2017 | - | $8.34 M(+14.7%) |
| Dec 2016 | $40.08 M(-1.8%) | $7.27 M(-16.4%) |
| Sep 2016 | - | $8.69 M(-13.9%) |
| Jun 2016 | - | $10.10 M(-28.0%) |
| Mar 2016 | - | $14.02 M(+34.3%) |
| Dec 2015 | $40.82 M(-11.4%) | $10.44 M(+22.6%) |
| Sep 2015 | - | $8.51 M(-19.1%) |
| Jun 2015 | - | $10.51 M(-7.5%) |
| Mar 2015 | - | $11.36 M(-8.4%) |
| Dec 2014 | $46.09 M(+2.7%) | $12.41 M(+14.3%) |
| Sep 2014 | - | $10.85 M(-9.8%) |
| Jun 2014 | - | $12.04 M(+11.5%) |
| Mar 2014 | - | $10.79 M(+4.4%) |
| Dec 2013 | $44.90 M(+18.1%) | $10.34 M(-4.9%) |
| Sep 2013 | - | $10.87 M(-1.1%) |
| Jun 2013 | - | $10.99 M(-13.4%) |
| Mar 2013 | - | $12.69 M(+0.6%) |
| Dec 2012 | $38.01 M(+51.5%) | $12.62 M(+26.2%) |
| Sep 2012 | - | $10.00 M(+13.4%) |
| Jun 2012 | - | $8.82 M(+34.0%) |
| Mar 2012 | - | $6.58 M(+11.5%) |
| Dec 2011 | $25.09 M(-1.7%) | $5.90 M(-4.3%) |
| Sep 2011 | - | $6.17 M(-6.2%) |
| Jun 2011 | - | $6.58 M(+2.2%) |
| Mar 2011 | - | $6.44 M(+6.8%) |
| Dec 2010 | $25.53 M(-12.6%) | $6.03 M(-2.8%) |
| Sep 2010 | - | $6.20 M(-0.4%) |
| Jun 2010 | - | $6.23 M(-11.8%) |
| Mar 2010 | - | $7.07 M(+19.7%) |
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2009 | $29.20 M(-32.1%) | $5.90 M(-15.0%) |
| Sep 2009 | - | $6.95 M(-9.1%) |
| Jun 2009 | - | $7.64 M(-12.2%) |
| Mar 2009 | - | $8.70 M(+5.0%) |
| Dec 2008 | $42.99 M(+7.6%) | $8.29 M(-20.7%) |
| Sep 2008 | - | $10.45 M(-16.5%) |
| Jun 2008 | - | $12.52 M(+6.6%) |
| Mar 2008 | - | $11.74 M(-3.6%) |
| Dec 2007 | $39.95 M(-5.1%) | $12.18 M(+30.5%) |
| Sep 2007 | - | $9.33 M(-9.0%) |
| Jun 2007 | - | $10.26 M(+25.5%) |
| Mar 2007 | - | $8.18 M(+2.9%) |
| Dec 2006 | $42.10 M(-1.3%) | $7.95 M(+0.2%) |
| Sep 2006 | - | $7.93 M(-20.2%) |
| Jun 2006 | - | $9.94 M(-39.0%) |
| Mar 2006 | - | $16.30 M(+27.3%) |
| Dec 2005 | $42.64 M(+9.0%) | $12.80 M(+22.0%) |
| Sep 2005 | - | $10.49 M(+5.4%) |
| Jun 2005 | - | $9.96 M(+6.1%) |
| Mar 2005 | - | $9.39 M(-21.7%) |
| Dec 2004 | $39.12 M(+53.6%) | $11.99 M(+39.8%) |
| Sep 2004 | - | $8.58 M(-10.1%) |
| Jun 2004 | - | $9.55 M(+6.2%) |
| Mar 2004 | - | $8.99 M(+1.7%) |
| Dec 2003 | $25.47 M(+28.6%) | $8.84 M(+36.7%) |
| Sep 2003 | - | $6.47 M(+25.7%) |
| Jun 2003 | - | $5.15 M(+2.7%) |
| Mar 2003 | - | $5.01 M(-12.1%) |
| Dec 2002 | $19.80 M(+51.5%) | $5.70 M(+11.6%) |
| Sep 2002 | - | $5.11 M(-2.9%) |
| Jun 2002 | - | $5.26 M(+40.7%) |
| Mar 2002 | - | $3.74 M(-18.2%) |
| Dec 2001 | $13.07 M(+3.4%) | $4.57 M(+72.2%) |
| Sep 2001 | - | $2.65 M(-12.5%) |
| Jun 2001 | - | $3.03 M(+7.7%) |
| Mar 2001 | - | $2.82 M(-60.0%) |
| Dec 2000 | $12.64 M(+138.9%) | $7.05 M(+219.7%) |
| Sep 2000 | - | $2.20 M(-12.3%) |
| Jun 2000 | - | $2.51 M(+66.5%) |
| Mar 2000 | - | $1.51 M(+17.0%) |
| Dec 1999 | $5.29 M(-33.0%) | $1.29 M(+61.3%) |
| Sep 1999 | - | $800.00 K(-33.3%) |
| Jun 1999 | - | $1.20 M(-40.0%) |
| Mar 1999 | - | $2.00 M(+11.1%) |
| Dec 1998 | $7.90 M(+27.4%) | $1.80 M(+38.5%) |
| Sep 1998 | - | $1.30 M(-45.8%) |
| Jun 1998 | - | $2.40 M(+4.3%) |
| Mar 1998 | - | $2.30 M(-51.1%) |
| Dec 1997 | $6.20 M(+148.0%) | $4.70 M(+1466.7%) |
| Sep 1997 | - | $300.00 K(-87.0%) |
| Jun 1997 | - | $2.30 M(+228.6%) |
| Mar 1997 | - | $700.00 K(-12.5%) |
| Dec 1996 | $2.50 M(0.0%) | $800.00 K(0.0%) |
| Sep 1996 | - | $800.00 K(+100.0%) |
| Jun 1996 | - | $400.00 K(-20.0%) |
| Mar 1996 | - | $500.00 K(-50.0%) |
| Dec 1995 | $2.50 M | - |
| Jun 1995 | - | $1.00 M(+150.0%) |
| Mar 1995 | - | $400.00 K |
FAQ
- What is Windtree Therapeutics annual total expenses?
- What is the all time high annual total expenses for Windtree Therapeutics?
- What is Windtree Therapeutics annual total expenses year-on-year change?
- What is Windtree Therapeutics quarterly total expenses?
- What is the all time high quarterly total expenses for Windtree Therapeutics?
- What is Windtree Therapeutics quarterly total expenses year-on-year change?
What is Windtree Therapeutics annual total expenses?
The current annual total expenses of WINT is $17.54 M
What is the all time high annual total expenses for Windtree Therapeutics?
Windtree Therapeutics all-time high annual total expenses is $46.09 M
What is Windtree Therapeutics annual total expenses year-on-year change?
Over the past year, WINT annual total expenses has changed by -$4.35 M (-19.87%)
What is Windtree Therapeutics quarterly total expenses?
The current quarterly total expenses of WINT is $4.74 M
What is the all time high quarterly total expenses for Windtree Therapeutics?
Windtree Therapeutics all-time high quarterly total expenses is $16.30 M
What is Windtree Therapeutics quarterly total expenses year-on-year change?
Over the past year, WINT quarterly total expenses has changed by +$51.00 K (+1.09%)